Answered step by step
Verified Expert Solution
Link Copied!

Question

1 Approved Answer

Covex Pharmaceuticals Sdn Bhd (Covex) is a company specializing in productions of pharmaceutical products. It has a financial year end every 31 March and owns

image text in transcribed

Covex Pharmaceuticals Sdn Bhd (Covex) is a company specializing in productions of pharmaceutical products. It has a financial year end every 31 March and owns a plant that it uses to produce and package vaccines. The plant was bought on 1 April 2017 at cost of RM1,500,000 and, at that date, it had an estimated useful life of five years. A review of the plant on 31 March 2019 concluded that the plants fair value was RM1,170,000. On 31 March 2020, Covex was informed by a major customer that it would no longer be placing orders with Covex, due to dissatisfaction over the vaccines produced by Covex since 2019. As a result, Covex revised its estimates that net cash inflows earned from the plant for the next three years will be: Year ended 31 March: RM 2021 250,000 2022 220,000 2023 254,000 Covexs cost of capital is 10%. On the same date, the plant has a fair value of RM530,000, The estimated cost to sell is RM40,000.

Required: i. Calculate the carrying amount of Covex's plant and the revaluation reserve at 31 March 2019. Prepare journal entries for the revaluation. (4 marks) ii. Calculate the recoverable amount of Covex's plant at 31 March 2020. (5 marks) iii. Prepare journal entries for the impairment loss of plant on 31 March 2020. (3 marks)image text in transcribed

T QUESTION 1 (25 MARKS) 1. Covex Pharmaceuticals Sdn Bhd (Covex) is a company specializing in productions of pharmaceutical products. It has a financial year end every 31 March and owns a plant that it uses to produce and package vaccines. The plant was bought on 1 April 2017 at cost of RM 1,500,000 and, at that date, it had an estimated useful life of five years. A review of the plant on 31 March 2019 concluded that the plant's fair value was RM1,170,000 On 31 March 2020, Covex was informed by a major customer that it would no longer be placing orders with Covex, due to dissatisfaction over the vaccines produced by Covex since 2019. As a result, Covex revised its estimates that net cash inflows eamed from the plant for the next three years will be: Year ended 31 March: 2021 2022 2023 RM 250,000 220,000 254,000 Covex's cost of capital is 10%. On the same date, the plant has a fair value of RM530,000, The estimated cost to sell is RM40.000 Required: Calculate the carrying amount of Covex's plant and the revaluation reserve at 31 March 2019. Prepare journal entries for the revaluation (4 marks) . Calculate the recoverable amount of Covex's plant ar 31 March 2020. (5 marks) Prepare journal entries for the impairment loss of plant on 31 March 2020. (3 marks) (Total: 12 Marks) 2. The accounting profit before tax for the year ended 31 December 2020 for dey Sdn Bhd amounted to RM37.000. The draft statement of financial December 2020 contained the following assets and liabilities: D Assets Cash Accounts receivables 2020 (RM) 23,000 24.000 20 T9001 28,000

Step by Step Solution

There are 3 Steps involved in it

Step: 1

blur-text-image

Get Instant Access to Expert-Tailored Solutions

See step-by-step solutions with expert insights and AI powered tools for academic success

Step: 2

blur-text-image

Step: 3

blur-text-image

Ace Your Homework with AI

Get the answers you need in no time with our AI-driven, step-by-step assistance

Get Started

Recommended Textbook for

Managerial Accounting

Authors: Susan V. Crosson, Belverd E. Needles

10th edition

1133940595, 978-1133940593

More Books

Students also viewed these Accounting questions

Question

_____ the legal contract between buyer and seller

Answered: 1 week ago

Question

_____ the loss of goods in inventory due to theft or spoilage

Answered: 1 week ago

Question

Compare the three basic types of locations.

Answered: 1 week ago